Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery

Depression is a debilitating psychiatric condition that remains the second most common cause of disability worldwide. Currently, depression affects more than 4 per cent of the world’s population. Most of the drugs intended for clinical management of depression augment the availability of neurotransm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Gui-Feng, Qin, Nan, Sun, Li-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605887/
https://www.ncbi.nlm.nih.gov/pubmed/28951668
http://dx.doi.org/10.1016/j.jsps.2016.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605887/
https://www.ncbi.nlm.nih.gov/pubmed/28951668
http://dx.doi.org/10.1016/j.jsps.2016.12.003

Ejemplares similares